BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2012
View Archived Issues
Resiniferatoxin improves urodynamic parameters in patients with overactive bladder
Read More
Solabegron demonstrates efficacy in phase II study
Read More
Long-term and post hoc phase III data presented on mirabegron
Read More
Ventana Medical Systems image analysis application cleared for use in U.S.
Read More
MorphoSys announces signing of protein engineering agreement
Read More
Affymax to receive milestone payment related to peginesatide
Read More
Watson Pharmaceuticals receives FDA complete response letter for vaginal gel
Read More
Ready-to-use oral therapy approved in China for oral mucositis in patients with cancer
Read More
Stem CentRx reports new APCDD1-binding antibodies
Read More
Bayer Schering Pharma patents novel potential anticancer agents
Read More
Novel antibacterials announced by Ranbaxy Laboratories
Read More
New aryl hydrocarbon receptor modulators developed in U.S.
Read More
New recombinant bacteria designed in Canada
Read More
Novartis identifies novel acetyl-CoA carboxylase 2 inhibitors
Read More
Study shows predictive value of PET/CT findings in retinoblastoma
Read More
Merck & Co. licenses Protein Sciences technology for vaccine research
Read More
Biodesix enters new collaboration
Read More
Advaxis reports data from first cohort in phase II ADXS-HPV trial
Read More
FDA grants priority review to Xarelto sNDA
Read More
Tranzyme Pharma and Norgine give update on ULISES 008 study
Read More
Two phase III cariprazine studies in schizophrenia meet primary endpoint
Read More
FDA grants fast track status to epicutaneous skin patch for peanut allergy
Read More
Apeiron begins study in prevention of radiation dermatitis
Read More
FDA grants Repros meeting to discuss Androxal development
Read More
Adocia's fast-acting human insulin comparable to NovoLog in phase IIa trial
Read More